Is Athira Pharma, Inc. (ATHA) a Buy, Sell, or Hold?
NASDAQ : ATHA
Athira Pharma, Inc. — Analyst Ratings
$6.75 USD
-$0.44 (-6.12%)
- Volume
- 70.31K
- Average Volume
- 1.06M
- Market Capitalization
- $26.62M
- P/E Ratio
- -0.26
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $8.36
- Year Low
- $2.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.38
Analyst Consensus Summary
Consensus Rating
N/A
5 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
68.8%
vs Current Price
Price Target
$4.00
Average TargetPrice Target Range
Lowest Target
$3.00
125.0% UPSIDE
Average Target
$4.00
Median Estimate
Highest Target
$33.00
-79.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 5
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 0 | 5 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Mizuho Securities | Graig Suvannavejh | $4 | $3.83 | 2025-09-19 07:02 AM | 4.4% |
| Jefferies | Andrew Tsai | $3 | $2.85 | 2022-06-22 02:52 PM | 5.3% |